| __timestamp | Sarepta Therapeutics, Inc. | argenx SE |
|---|---|---|
| Wednesday, January 1, 2014 | 94231000 | 15411924 |
| Thursday, January 1, 2015 | 146394000 | 22593274 |
| Friday, January 1, 2016 | 188272000 | 33173050 |
| Sunday, January 1, 2017 | 166707000 | 62224159 |
| Monday, January 1, 2018 | 401843000 | 95607434 |
| Tuesday, January 1, 2019 | 560909000 | 221269028 |
| Wednesday, January 1, 2020 | 722343000 | 400745069 |
| Friday, January 1, 2021 | 771182000 | 580520000 |
| Saturday, January 1, 2022 | 877090000 | 663366000 |
| Sunday, January 1, 2023 | 877387000 | 755113687 |
Unleashing the power of data
In the competitive world of biotechnology, innovation is the lifeblood of success. Over the past decade, two companies, Sarepta Therapeutics, Inc. and argenx SE, have been at the forefront of this race. From 2014 to 2023, Sarepta Therapeutics consistently outpaced argenx SE in research and development (R&D) spending, with a peak investment in 2022 that was approximately 33% higher than argenx's. However, argenx SE has shown remarkable growth, increasing its R&D expenses by nearly 49 times from 2014 to 2023. This surge reflects argenx's commitment to catching up with its rival. As of 2023, the gap has narrowed significantly, with argenx spending just 14% less than Sarepta. This trend highlights the dynamic nature of the biotech industry, where strategic investments in innovation can rapidly alter competitive landscapes.
Bristol-Myers Squibb Company vs Sarepta Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for argenx SE and Alnylam Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for argenx SE and Dr. Reddy's Laboratories Limited
argenx SE or Opthea Limited: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for argenx SE and ADMA Biologics, Inc.
Research and Development Investment: argenx SE vs Catalyst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for argenx SE and Bausch Health Companies Inc.
R&D Spending Showdown: argenx SE vs Veracyte, Inc.
United Therapeutics Corporation or Sarepta Therapeutics, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs Ionis Pharmaceuticals, Inc.
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs ImmunityBio, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Sarepta Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.